Year-over-year articles
ADJUTEC PHARMA AS
7 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 923 831 762
Stronger earnings, fresh owner capital
Comparing Årsregnskap 2025 with 2024 for ADJUTEC PHARMA AS. Net result -1.46m NOK → -1.12m NOK. Equity 33.34m NOK → 47.22m NOK.
Shrank 100% on revenue, stronger earnings, fresh owner capital
Comparing Årsregnskap 2024 with 2023 for ADJUTEC PHARMA AS. Revenue 7.33m NOK → 7 333 NOK (-99.9%). Net result -9.53m NOK → -1.46m NOK. Equity 18.07m NOK →…
Shrank 6% on revenue, stronger earnings, cash halved-plus
Comparing Årsregnskap 2023 with 2022 for ADJUTEC PHARMA AS. Revenue 7.84m NOK → 7.33m NOK (-6.5%). Net result -17.15m NOK → -9.53m NOK. Equity 27.60m NOK →…
Grew 124829% on revenue, weaker earnings, fresh owner capital
Comparing Årsregnskap 2022 with 2021 for ADJUTEC PHARMA AS. Revenue 6 277 NOK → 7.84m NOK (+124828.7%). Net result -3.52m NOK → -17.15m NOK. Equity 32.76m…
Grew 926% on revenue, weaker earnings, fresh owner capital
Comparing Årsregnskap 2021 with 2020 for ADJUTEC PHARMA AS. Revenue 612 NOK → 6 277 NOK (+925.7%). Net result -747.3k NOK → -3.52m NOK. Equity 1.28m NOK →…
Fresh owner capital
Comparing Årsregnskap 2020 with 2019 for ADJUTEC PHARMA AS. Revenue 0 NOK → 612 NOK. Equity 24.4k NOK → 1.28m NOK.
First published accounts
First year in the published series for ADJUTEC PHARMA AS (2019). No prior-year comparative in this dataset.